XML 45 R35.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue Recognition (Details) - Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Profit (Loss) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
[1]
Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Profit (Loss) [Line Items]          
Revenue $ 986,308 $ 646,828 $ 2,596,671 $ 1,794,385  
Cost of revenue 239,247 196,535 753,735 553,467  
Gross profit 747,061 450,293 $ 1,842,936 1,240,918  
Gross Profit %     70.97%    
Assets 3,228,302   $ 3,228,302   $ 2,879,103
Net profit (loss) (887,146) $ (5,857,159) (4,924,786) $ (9,557,629)  
Global Stem Cells Group [Member]          
Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Profit (Loss) [Line Items]          
Revenue     2,596,671    
Cost of revenue     753,735    
Gross profit     $ 1,842,936    
Gross Profit %     70.97%    
Assets 1,314,936   $ 1,314,936    
Net profit (loss)     (50,716)    
Meso Numismatics [Member]          
Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Profit (Loss) [Line Items]          
Revenue        
Cost of revenue        
Gross profit        
Gross Profit %     0.00%    
Assets $ 1,913,366   $ 1,913,366    
Net profit (loss)     $ (4,874,069)    
[1] Derived from audited information